Professional Seasonal Analysis for Trading

Neurocrine Biosciences, Inc. - Common Stock (NBIX)

Seasonality Analysis

Stocks 27 Years Analyzed

Neurocrine Biosciences, Inc. - Common Stock Annual Seasonality Statistics

19.06%
Avg Annual Return
53.9%
Avg Monthly Win Rate
10/12
Positive Months
27
Years Analyzed

Neurocrine Biosciences, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 6.62%
56%
Moderate
February -1.98%
37%
Very Weak
March 0.70%
48%
Weak
April 0.77%
52%
Moderate
May 2.76%
58%
Moderate
June 3.05%
58%
Moderate
July 0.53%
50%
Weak
August 4.20%
58%
Moderate
September WORST -2.62%
50%
Weak
October 2.36%
58%
Moderate
November 0.46%
58%
Moderate
December 2.22%
65%
Strong

Neurocrine Biosciences, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
46.46
Historical Avg Position
35.33
Deviation
+11.13
Performance
Significantly Above Average

Neurocrine Biosciences, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for NBIX with overlay patterns, custom date ranges, and more.

Create Free Account

Neurocrine Biosciences, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Neurocrine Biosciences, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for NBIX across multiple timeframes.

Create Free Account

About Neurocrine Biosciences, Inc. - Common Stock (NBIX) Seasonality

Neurocrine Biosciences, Inc. - Common Stock (NBIX) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Neurocrine Biosciences, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Neurocrine Biosciences, Inc. - Common Stock is historically January, with an average return of 6.62% and a win rate of 56%. Conversely, September tends to be the weakest month, averaging -2.62% return.

Looking at the full calendar year, Neurocrine Biosciences, Inc. - Common Stock has an average annual return of 19.06% with an overall monthly win rate of 53.9%. Out of 12 months, 10 typically show positive average returns.

The seasonal pattern for Neurocrine Biosciences, Inc. - Common Stock has a consistency score of 38.5 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Neurocrine Biosciences, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Neurocrine Biosciences, Inc. - Common Stock (NBIX)?

Historically, January has been the best month for Neurocrine Biosciences, Inc. - Common Stock, with an average return of 6.62% and a win rate of 56%. However, past performance does not guarantee future results.

What is the worst month for Neurocrine Biosciences, Inc. - Common Stock (NBIX)?

Based on historical data, September has been the weakest month for Neurocrine Biosciences, Inc. - Common Stock, with an average return of -2.62%. This is a historical observation and does not guarantee future results.

How reliable is NBIX seasonality data?

The seasonality analysis for Neurocrine Biosciences, Inc. - Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Neurocrine Biosciences, Inc. - Common Stock seasonality in my trading?

Use Neurocrine Biosciences, Inc. - Common Stock (NBIX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.